In:
Blood Advances, American Society of Hematology, Vol. 3, No. 22 ( 2019-11-26), p. 3575-3578
Kurzfassung:
This is the first-ever demonstration of successful treatment of paroxysmal cold hemoglobinuria using the complement inhibitor eculizumab.
Materialart:
Online-Ressource
ISSN:
2473-9529
,
2473-9537
DOI:
10.1182/bloodadvances.2019000897
Sprache:
Englisch
Verlag:
American Society of Hematology
Publikationsdatum:
2019
ZDB Id:
2876449-3